Senator Jeff Hayden (DFL-Minneapolis) is teaming up with Sen. Hayden’s constituents, Matthew and Gabe Roderick, and the Jablonski family to create a research grant program aimed at creating new and innovative treatments and rehabilitative efforts for spinal cord and traumatic brain injuries. The “Jablonski/Rodreick spinal cord and traumatic brain injury grant program” will be introduced this week.
The legislation will invest $8 million into a grant program that awards grants to publicly funded research institutions for research into spinal cord injuries and traumatic brain injuries.
“Our family is honored to have our son’s name on a bill that is crucial to our mission of seeing Jack walk again. We’re extremely grateful to Matthew Rodreick and Senator Jeff Hayden for introducing the bill to the Legislature,” said Leslie Jablinski (Jack’s mom). “Their efforts have raised awareness for spinal cord injury research and the importance of significant funding. We believe a cure is possible and with the financial support of our government, it could be attained in our own backyard.”
Leading the charge for the legislation is Matthew Rodreick. His son, Gabe, suffered from a spinal cord injury four years ago and their family has been working to find the right combination of therapy to deliver the most functional recovery possible. “I believe this legislation puts us into the race for the cure here in Minnesota and is an investment not just in the human needs of our fellow Minnesotans, but also an opportunity to invest in the research that will end paralysis for everyone,” said Mr. Rodreick.
Introducing the bill in the House, Rep. Halverson is hopeful the grant will have a quick and lasting impression. “We need to be supporting vital lives for people with disabilities and this grant money and research can help do just that,” said Rep. Halverson. “We have an opportunity to find breakthroughs that will make an immeasurably positive difference in the lives of thousands of Minnesotans. This bill is coming to us with inspiring grassroots support from the disability community and I’m hopeful we can get it passed this year.”
- Stroke Drug Boosts Stem Cell Therapy For Spinal Cord Injury In Rats
- An integrated in silico pipeline identifies a novel TF combination that promotes enhanced CST growth following injury
- Spike timing-dependent plasticity in the adult rat with chronic cervical spinal cord contusion
- Effect of PTEN antagonist peptide on the functional motor recovery in rat
- GDF10 promotes axonal regeneration and functional recovery: A novel gene therapy strategy for spinal cord injury
- GTX Medical and NeuroRecovery Technologies to merge
- Candidate Therapy From Quebec for Chronic SCI Being Developed in Parallel by Academics and Companies in Switzerland and the Netherlands
- Moving beyond the glial scar for spinal cord repair
- The Struggle to Make CNS Axons Regenerate: Why Has It Been so Difficult?
- The potential of electric field for promoting neurite guidance in spinal cord injury regeneration strategies
- Extraction and selective activation of muscle synergies through spinal stimulation for SCI
- Early limb unloading elicits long-term motor deficits involving motorneuron hyperexcitability associated with persistent alterations in glutamatergic synaptic plasticity in spinal cord injury
- The effects of a pro-angiogenic, RGD-functionalized, nanofiber composite biomaterial on mesenchymal stem cell-mediated repair of the injured spinal cord
- From wheelchair to walking after spinal cord injury
- ReNetX Bio, Inc. Announces U.S. FDA Authorization to Proceed for IND Application to Treat Patients with Chronic Spinal Cord Injury
Follow on TwitterMy Tweets